Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Donanemab raised the risk of amyloid-related imaging abnormalities (ARIA) in Alzheimer's patients. Many ARIA events ...

FIRST ON FOX: A new book sounding the alarm about corruption in California spends a chapter focusing on Gov. Gavin Newsom’s history with a nonprofit organization that the authors say served as a ...

But some experts have long warned that side effects of the drug — called donanemab — massively outweigh its benefits. Now, a new study from the company that produces the medication itself ...

But some experts say the side effects of the drug called donanemab may outweigh its benefits. It was given the green light by UK drug regulators, the Medicines and Healthcare Products Regulatory ...

Headlines about the results of TRAILBLAZER-ALZ2 trial of Eli Lilly’s Alzheimer’s drug candidate donanemab are spreading around the world, with some going as far as to suggest this could herald ...

Lilly has also picked up an accelerated review for donanemab from the FDA, which is assessing the drug under a rolling license application that will see data submitted to the agency as it becomes ...

Death Stranding 2 will release for PS5 on 26th June 2025, except it actually doesn't — if you wait until the official launch date, you'll already be two days late. Publishers are increasingly ...

Early diagnosis is crucial in disease prevention and treatment. Many diseases can be identified not just through physical ...

bubbling under hot 100 the week’s most popular current songs across all genres below no. 100, ranked by streaming activity data by online music sources tracked by luminate, radio airplay ...

While researchers continue to work on a full cure for Alzheimer's disease, they're finding treatments that can help manage symptoms and delay their onset, including the recently approved next-gen ...

In a phase 3 randomized clinical trial, donanemab slowed clinical disease progression in amyloid-positive, early symptomatic Alzheimer’s patients over 76 weeks. The drug is currently under regulatory ...